CYP1B1-IN-1

CAS No. 842122-33-2

CYP1B1-IN-1( —— )

Catalog No. M35463 CAS No. 842122-33-2

CYP1B1-IN-1 is a selective and highly potent cytochrome P450 1B1 (CYP1B1) inhibitor with potential anticancer and antitumor activity for breast cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1017 In Stock
10MG 1359 In Stock
25MG 2024 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CYP1B1-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    CYP1B1-IN-1 is a selective and highly potent cytochrome P450 1B1 (CYP1B1) inhibitor with potential anticancer and antitumor activity for breast cancer research.
  • Description
    CYP1B1-IN-1 (Compound 9e) is a selective cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 0.49 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    842122-33-2
  • Formula Weight
    306.74
  • Molecular Formula
    C19H11ClO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C=C(OC2=C1C=CC=3C=CC=CC32)C=4C=CC=C(Cl)C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dong J, et al. Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. Eur J Med Chem. 2020 Feb 1;187:111938. ?
molnova catalog
related products
  • CDD3506

    CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.

  • Toddalolactone

    anti-inflammatory and analgesic.

  • AS1810722

    AS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.